ORCID: https://orcid.org/0000-0002-4703-537X; Cadilha, Bruno L. und Kobold, Sebastian
ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Flow cytometry detection and quantification of CAR T cells into solid tumors.
In: Methods in Cell Biology, Vol. 167: pp. 99-122
Abstract
Adoptive T cell therapy (ACT) is a therapeutic approach which employs genetically manipulated autologous T cells to target and eliminate a patient's malignancy. This novel therapeutic approach, when employing a chimeric antigen receptor (CAR) targeting CD19-expressing B cells, has shown remarkable success in treating acute B-cell lymphocytic leukemia. However, blood born malignancies represent only a fraction of cancers which affect patients. Unfortunately, the utilization of ACT to target solid malignancies has only shown marginal success rates. There are many known obstacles which hinder CAR T cell therapy in patients suffering from solid cancer, one notable obstacle is the effective trafficking of CAR T cells to the tumor site. With the rapid advancement of novel approaches and targets which may enhance CAR T cell infiltration into solid tumors, a standardized approach to assess and measure CAR T cell infiltration becomes imperative in order to compare these different approaches across platforms. Here we describe a flow cytometry method which enables the rapid detection and quantification of CAR T cells which have reached and entered the tumor mass following intravenous injection. Competence with single cell preparation and flow cytometry is required for optimal results.
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Medical Center of the University of Munich > Medical Clinic and Outpatient Clinic IV (Endocrinology, nephrology, other sections) |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0091-679X |
| Language: | English |
| Item ID: | 109813 |
| Date Deposited: | 06. Mar 2024 15:13 |
| Last Modified: | 06. Mar 2024 15:13 |
